Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 18.78% | 15.46% | 52.64% | 10.29% | 1.40% |
Total Depreciation and Amortization | 5.13% | 6.38% | 5.97% | 3.89% | 8.47% |
Total Amortization of Deferred Charges | 101.35% | 93.66% | 114.62% | 171.21% | 229.59% |
Total Other Non-Cash Items | 25.04% | 62.29% | -122.16% | 38.51% | 15.82% |
Change in Net Operating Assets | -47.49% | -66.97% | -19.84% | 29.00% | 181.67% |
Cash from Operations | 39.81% | 35.98% | 32.27% | 28.71% | 17.51% |
Capital Expenditure | 50.82% | 40.08% | -404.74% | -1,190.76% | -86.82% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -100.00% | -98.70% | -95.71% | -25.26% |
Cash from Investing | -105.88% | -104.24% | -103.18% | -100.18% | -30.26% |
Total Debt Issued | 152.32% | 152.32% | -100.00% | -- | -- |
Total Debt Repaid | -15.92% | 14.51% | -41.23% | 7.81% | 2.42% |
Issuance of Common Stock | 275.05% | 270.84% | -59.46% | -50.70% | -87.92% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 46.34% | 61.51% | 77.47% | -2,241.15% | -1,843.23% |
Cash from Financing | 199.96% | 215.80% | -70.88% | -34.76% | -71.49% |
Foreign Exchange rate Adjustments | 344.00% | -209.05% | 153.28% | 101.20% | 19.87% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 113.00% | 97.50% | -183.78% | -193.96% | -355.98% |